340: Mountain Biking: An Evolving Mechanism of injury von Flaherty, S.K, Charles, M

Volltext

133 Sepsis and Empiric Antibiotics: Should We Consider “Health Care Associated” Urinary Tract Infections? von Flaherty, S.K, Weber, R, Dugas, A, Cocchi, M, Salciccioli, J, Donnino, M

Volltext

A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma von Goyal, L, DiToro, D, Facchinetti, F, Martin, E E, Peng, P, Baiev, I, Iyer, R, Maurer, J, Reyes, S, Zhang, K, Majeed, U, Berchuck, J E, Chen, C T, Walmsley, C, Pinto, C, Vasseur, D, Gordan, J D, Mody, K, Borad, M, Karasic, T, Damjanov, N, Danysh, B P, Wehrenberg-Klee, E, Kambadakone, A R, Saha, S K, Hoffman, I D, Nelson, K J, Iyer, S, Qiang, X, Sun, C, Wang, H, Li, L, Javle, M, Lin, B, Harris, W, Zhu, A X, Cleary, J M, Flaherty, K T, Harris, T, Shroff, R T, Leshchiner, I, Parida, L, Kelley, R K, Fan, J, Stone, J R, Uboha, N V, Hirai, H, Sootome, H, Wu, F, Bensen, D C, Hollebecque, A, Friboulet, L, Lennerz, J K, Getz, G, Juric, D

Volltext

A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Results von Buti, M, Gane, E, Seto, W.K, Chan, H.L.Y, Chuang, W.-L, Stepanova, T, Hui, A.J, Lim, Y.-S, Mehta, R, Janssen, H.L.A, Acharya, S.K, Flaherty, J.F, Massetto, B, Cathcart, A, Dinh, P, Subramanian, G.M, McHutchison, J.G, Pan, C, Brunetto, M, Izumi, N, Marcellin, P

Volltext

A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Positive Chronic Hbv: Week 48 Efficacy and Safety Results von Chan, H.L.Y, Fung, S, Seto, W.K, Chuang, W.-L, Chen, C.-Y, Kim, H.J, Hui, A.J, Janssen, H.L.A, Chowdhury, A, Tsang, T.Y.O, Mehta, R, Gane, E, Flaherty, J.F, Massetto, B, Kitrinos, K, Dinh, P, Subramanian, G.M, McHutchison, J.G, Lim, Y.-S, Acharya, S.K, Agarwal, K

Volltext

GS12 - A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Positive Chronic Hbv: Week 48 Efficacy and Safety Results von Chan, H.L.Y., Fung, S., Seto, W.K., Chuang, W.-L., Chen, C.-Y., Kim, H.J., Hui, A.J., Janssen, H.L.A., Chowdhury, A., Tsang, T.Y.O., Mehta, R., Gane, E., Flaherty, J.F., Massetto, B., Kitrinos, K., Dinh, P., Subramanian, G.M., McHutchison, J.G., Lim, Y.-S., Acharya, S.K., Agarwal, K.

Volltext

GS06 - A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Result... von Buti, M., Gane, E., Seto, W.K., Chan, H.L.Y., Chuang, W.-L., Stepanova, T., Hui, A.J., Lim, Y.-S., Mehta, R., Janssen, H.L.A., Acharya, S.K., Flaherty, J.F., Massetto, B., Cathcart, A., Dinh, P., Subramanian, G.M., McHutchison, J.G., Pan, C., Brunetto, M., Izumi, N., Marcellin, P.

Volltext

Racemic ketamine in comparison to S-ketamine in combination with azaperone and butorphanol for castration of pigs von Bettschart-Wolfensberger, R, Stauffer, S, Ringer, S. K., Universitaet Zuerich, Zuerich (Switzerland). Pferdeklinik, Hässig, M, Flaherty, D

Volltext